ANAPTYSBIO INC
For the period ended Dec 31, 2023. Filed Mar 11, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 11, 2024
ANAB$48.38+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Financial Statements Consolidated Balance Sheets
(in thousands, except par value)
| December 31, 2023 | December 31, 2022 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $35,965 | $71,308 |
| Receivables from collaborative partners | 6,851 | 1,419 |
| Short-term investments | 354,939 | 369,933 |
| Prepaid expenses and other current assets | 9,080 | 4,545 |
| Total current assets | 406,835 | 447,205 |
| Property and equipment, net | 2,098 | 2,089 |
| Operating lease right-of-use assets | 16,174 | 17,898 |
| Long-term investments | 27,026 | 142,935 |
| Other long-term assets | 256 | 256 |
| Total assets | $452,389 | $610,383 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $4,698 | $2,784 |
| Accrued expenses | 30,967 | 21,633 |
| Current portion of operating lease liability | 1,777 | 1,637 |
| Total current liabilities | 37,442 | 26,054 |
| Liability related to sale of future royalties | 310,807 | 304,413 |
| Operating lease liability, net of current portion | 16,037 | 17,813 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000 shares authorized and no shares, issued or outstanding at December 31, 2023 and December 31, 2022, respectively | — | — |
| Common stock, $0.001 par value, 500,000 shares authorized, 26,597 shares and 28,513 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 27 | 29 |
| Additional paid in capital | 702,969 | 717,797 |
| Accumulated other comprehensive loss | (797) | (5,246) |
| Accumulated deficit | (614,096) | (450,477) |
| Total stockholders’ equity | 88,103 | 262,103 |
| Total liabilities and stockholders’ equity | $452,389 | $610,383 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.